FDA Device recall Z-0578-2015
Oxoid Legionella BCYE Growth Supplement packaged in packs of 10-100ml vials
- FDA Device
- Class II
- terminated
- Published 2014-12-17
On 2014-12-17 the FDA classified a Class II recall of Oxoid Legionella BCYE Growth Supplement packaged in packs of 10-100ml vials by Remel, citing use of the product could result in inadequate recovery of Legionella pneumophila which could result in false negative reporting.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0578-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-11-13 |
| Published | 2014-12-17 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Remel |
| Distribution | US |
Product
Oxoid Legionella BCYE Growth Supplement packaged in packs of 10-100ml vials. A growth supplement for the isolation of Legionella.
Reason
Use of the product could result in inadequate recovery of Legionella pneumophila which could result in false negative reporting.
Identifiers
| code_info | Lot number: 1374439, Exp: 31 Aug 2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0578-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.